Anti-transthyretin Antibodies


The invention provides antibodies that specifically bind to transthyretin (TTR). The antibodies can be used for treating or effecting prophylaxis of diseases or disorders associated with TTR accumulation or accumulation of TTR deposits (e.g., TTR amyloidosis). The antibodies can also be used for diagnosing TTR amyloidosis and inhibiting or reducing aggregation of TTR, among other applications.

Family Member PDF
Family Member Preview
These are the images from a related family member, as the full document isn't yet available to us from the patent office.
Document History
  • Publication: Aug 4, 2016
  • Application: Jan 28, 2016
    WO IB 2016050416 W
  • Priority: Dec 11, 2015
    US US 201562266555 P
  • Priority: Jan 28, 2015
    US US 201562109004 P

Download Citation

Sign in to the Lens